Home Compliance DOJ’s Granston Memo and Recent Government-Requested Dismissal of False Claims Act Case... ComplianceExpert OpinionNews DOJ’s Granston Memo and Recent Government-Requested Dismissal of False Claims Act Case Have Significant Implications for FDA-Regulated Entities December 3, 2019 37 Share FacebookLinkedinTwitter Panchenko Vladimir | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Expert Opinion The Next Frontier: Key Takeaways from the New U.S. Government Commercial Space Strategies Compliance Relator’s Claims Against Federal Grantees Survive Motion to Dismiss Compliance Not an April Fools Joke – FAR Part 40 Final Rule Has Been Published